Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Recent Reports State That 19 Million Americans Abuse Prescription Drugs; FDA and Novus Medical Detox Agree That Education is Needed
  • USA - English


News provided by

JoTo PR

Aug 11, 2014, 09:00 ET

Share this article

Share toX

Share this article

Share toX


New Port Richey, FL (PRWEB) August 11, 2014 -- Reports from the Centers for Disease Control and Prevention (CDC) state that 46 Americans die every day from prescription drug overdose, which adds up to about 17,000 deaths annually. The reports also state that poisonings by drug overdose have tripled over the past 30 years. (1) Novus Medical Detox, one of the only Florida-based detox centers serving high-dosage drug abuse patients, states that the reason behind the high number of fatalities lies in inadequate drug education.

Intentionally or not, Americans may be underestimating the highly addictive nature of drugs such as opioids.

Post this

The Food and Drug Administration (FDA) carries this same belief, and has responded by implementing a new drug education program. The program seeks to educate doctors who prescribe these highly-addictive painkillers, as well as the patients who are taking them. The program’s mission is “to teach doctors about proper opiate prescribing for pain patients to minimize the risks of diversion and addiction.” (4)

The United Nation’s World Drug Report 2014 stated that in 2012, 6.1% (19 million) of Americans abused prescription opioids, including morphine, codeine, OxyContin and Vicodin. This figure categorizes the United States as a country that abuses prescription drugs more than any other country in the world. (2) In an effort to lower the number of people harmed by these drugs, Novus warns Americans to exercise caution when receiving a new prescription from a physician, and to ask questions related to its side effects.

“Intentionally or not, Americans may be underestimating the highly addictive nature of drugs such as opioids,” stated Novus Executive Director Kent Runyon. “It may start as nothing more than filling a prescription for legitimate pain, but overdose may result when a patient seeks to elicit a stronger high from these drugs.”

Novus recommends that the following steps be taken when being prescribed a new medication (3):

● Be sure that the prescription comes from a trusted physician;
● Only use the medication as prescribed;
● Ask the physician about the medicine and its effects;
● Conduct your own research about the drug’s effects; and
● Be prepared—ask your doctor what to do if one becomes addicted.

All of these tips are important to heed before a patient starts to take a medication, because addiction may begin with the patient being unaware of a medication’s initial effects. This patient may begin to take pills more liberally than prescribed, and the dangers of addiction do not lie far behind.

Runyon maintains that comprehensive drug education, starting in grade school and continuing throughout adult life to physician visits, can help to significantly reduce the number of Americans addicted to such drugs.

While new preventative measures are being taken, Novus recommends looking out for the following symptoms or behaviors (but not limited to), if someone suspects that a loved one is abusing pain reliever prescription drugs (5):

● Nausea, drowsiness;
● Mood swings and anxiety;
● Slowed reactions, movement and breathing;
● Jittery or secretive; and/or
● Neglect of work/school responsibilities.

Runyon advises those who are dependent upon any abusive substance(s) to seek out safe, medically-supervised detox programs, and to use those with integrated medicine that allows the detox process to be as comfortable as possible.

For more information on Novus Medical Detox’s addiction and detox programs, visit http://www.NovusDetox.com.

About Novus Medical Detox Center:

Novus Medical Detox Center offers safe, effective alcohol and drug treatment programs in a home-like residential setting. Located on 3.25 tree-lined acres in New Port Richey, Fla., Novus is licensed by the Florida Department of Children and Families as an inpatient medical detox facility. Novus is known for minimizing the discomfort of withdrawal from prescription medication, drugs or alcohol by creating a customized detox program for each patient, incorporating medication, natural supplements and fluid replenishment—putting the dignity and humanity back into drug detoxification. Patients have 24/7 medical supervision, including round-the-clock nursing care and access to a withdrawal specialist, and enjoy comfortable private or shared rooms with a telephone, cable television, and high-speed Internet access. For more information, visit http://www.novusdetox.com.

1.Hutchins, Sarah. “Drug Overdose: Prescription Painkillers Poison 46 Americans Every Day.” Liberty Voice, 20 July 2014. Web. 22 July 2014. guardianlv.com/2014/07/drug-overdose-prescription-painkillers-poison-46-americans-every-day/.

2.Blake, Matthew. “Extent of US Dependency on Prescription Drugs Revealed: UN Report Shows 6% of American Adults Hooked on Pills.” Mail Online. Associated Newspapers, 07 July 2014. Web. 21 July 2014. dailymail.co.uk/news/article-2683318/Extent-US-dependency-prescription-drugs-revealed-UN-report-shows-6-American-adults-hooked-pills.html.

3.Winkel, Bethany. “Avoiding Prescription Drug Abuse—Treatment Solutions.” Treatment Solutions. N.p., 11 Feb. 2010. Web. 23 July 2014. treatmentsolutions.com/avoiding-prescription-drug-abuse/.

4.Sack, David. “FDA Prescription Drug Abuse Plan Hits—and Misses—the Mark—Addiction Recovery.” Addiction Recovery with David Sack, M.D. Psych Central.com, 7 July 2014. Web. 22 July 2014. blogs.psychcentral.com/addiction-recovery/2014/07/fda-prescription-drug-abuse-plan-hits-and-misses-the-mark/.

5.“Signs and Symptoms of Prescription Pain Reliever Abuse.” Narconon International, n.d. Web. 22 July 2014. narconon.org/drug-abuse/signs-symptoms-pain-relievers.html.

Karla Jo Helms, JoTo PR, +1 (888) 202-4614 Ext: 802, [email protected]

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.